GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

The FreeStyle Libre by Abbott can provide prick-free on-demand sugar readings that offer detailed insights with just a scan ...

Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...

The wearables category already contains multitudes, from exercise-focused smart watches and sleep tracking smart rings to ...

Ultimately, the right stocks for your portfolio will depend on numerous factors, including your risk tolerance level, ...

Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 <a tar ...

Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...

GAMMA Investing LLC increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 17.0% ...

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Innovative fingertip biofuel cells and flexible thermoelectric devices enable non-invasive biomarker sensing and energy ...